In our study, we found downstream target SOX5 of SLNCR1 from the perspective of lncRNA transcriptional regulation and clarified that SLNCR1/SOX5 axis promotes invasion and metastasis of melanoma through EMT, suggesting that SLNCR1 could be used as a potential biomarker and therapeutic target for melanoma. This evidence concerns the gene LINC00511 and melanoma.